(Q44328417)

2 December 2017

Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G. (English)

1 reference

2 December 2017

Dominique Ledoux

1

1 reference

2 December 2017

Didier Merciris

series ordinal

2

1 reference

2 December 2017

Denis Barritault

series ordinal

3

1 reference

2 December 2017

Jean Pierre Caruelle

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

537

1 reference

2 December 2017

1-3

1 reference

2 December 2017

23-29

1 reference

Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Heparin-like polymer improved healing of gastric and colic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Catalysis by human leukocyte elastase: mechanistic insights into specificity requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Heparin-induced conformational change and activation of mucus proteinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

DNA strongly impairs the inhibition of cathepsin G by alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Inhibition of cathepsin G by 2-amino-3,1-benzoxazin-4-ones: kinetic investigations and docking studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Inhibition of Neutrophil Serine Proteinases by Suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

New approaches to tissue regeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Heparan-like molecules induce the repair of skull defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Human plasmin enzymatic activity is inhibited by chemically modified dextrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Theoretical and practical aspects of proteinase inhibition kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Heat-induced conversion of ovalbumin into a proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Inhibition of cathepsin G by 4H-3,1-benzoxazin-4-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

New agents for the treatment of infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

A re-evaluation of the kinetic equations for hyperbolic tight-binding inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900064-4

10.1016/S0014-5793(03)00064-4

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference